@drdanigordon one on one #interview with #h**pandcbdmedia A thoroughly interesting listen!! Check out the full interview with Dr. Dani over on our YouTube channel and let us know what you think! 🌱Don’t forget, you can hear Dani speaking this September 14th-15th at the @h**pandcbdexpo #seminars
Available Now on our YouTube! H**p & CBD Media interview Mike Harlington of the @cannabistradesuk
In this interview Mike discusses the role the CTA plays in the CBD industry and the work they are doing behind the scenes for their members and the industry as a whole. The CTA is a non profit whose focus is primarily on cannabinoids.
'Essentially the CTA stands for making sure that we have a safe, legal, legitimate, and regulated industry, because if we don't have that, you won't be in business!'
Find out more about the CTA at their stand in the 'Compliance Corner' at the upcoming H**p & CBD Expo this September 14-15th and listen to Mike Harlington speak at the seminar stage.
You can also visit their website
www.cannabistrades.org
https://youtu.be/phCHW6ItMYk
🌱 COMING SOON: H**p & CBD Media interviews Jamie Bartley
Jamie is a Leicestershire based UK h**p farmer who is looking to help educate other farmers in this country to look past the stigma associated with #cannabis and focus on what #h**p can do for the UK #economy and #environment And the many practical uses of #industrialh**p
Check out the full interview COMING SOON to the #h**pandcbdmedia YouTube and www.h**pandcbdmedia.com
Hannah Deacon Interview: Concerns of ‘Lack of understanding’ from outdated NICE interim guidance for cannabis based medicine
Hannah Deacon Interview: Concerns of ‘Lack of understanding’ from outdated NICE interim guidance for cannabis based medicine
HCM Interviews Hannah Deacon, mother of Alfie Dingley, to ask what she thinks of the NICE (National Institute for Health and Care Excellence) interim guidance for cannabis-based medicinal products - released yesterday, August 8th, 2019.
A brief summary of the review indicates that more evidence, and randomized controlled trials are needed to fully understand the long term effects and side effects of cannabis based medicines on patients, stating there is simply not enough evidence that it is safe.
When asked for her thoughts on NICE’s findings Hannah said
“I think this is absolutely ridiculous! Are we saying that every country in the world with a medical cannabis legislation is wrong? Are we that arrogant?
I think that we are pharmaceuticalizing cannabis, and that is wrong. It does not lend itself to a randomized controlled trial process, because of the nature of the plant.”
Hannah moves on to to say “Until the exceptionality of this medicine is accepted, we’re not going to move forward, I don’t think. I think that is extremely sad, I think NICE are outdated”
Hannah openly states that she, herself applied to be on the panel. She was told that she could be, but only if sacrificing any media opportunities, or being able to talk about her feelings about cannabis.
Hannah points to the hypocrisy of the situation stating
“I know there are people on that panel, that have created that guidance, who have openly in the last year, talked to the media about their concerns about cannabis medicine.
My feeling is that there is a real question to be asked of these people that actually wrote this guidance, and it’s very very concerning, and I’m very very upset and angry about it, because all it does is block access!
Children, and the families I work with, they haven’t got 10, 15, 20 years to wait for randomized controlled trials, and actually what
HCM interviews CBD Intel’s Tim Phillips - The H**p & CBD Media team caught up with Tim Phillips from CBD Intel to discuss where his company sees the CBD industry currently, and what he makes of the overwhelming interest in CBD from both the public and business investor perspectives.
CBD Intel’s objectives and main areas of expertise lie in providing legal data on the current legislation and regulations surrounding CBD in global markets.
Additionally, the company provides market data from a consumer perspective, and also from brand and products basis to see what is available on the market and how they are selling.
Tim explains that upon setting up CBD Intel in 2018, CBD was perceived as a “minority interest” of a widespread booming cannabis sector, however, he sees a rapidly growing interest (especially from within Europe) from cannabis based companies previously more involved in recreational and medicinal uses.
Watch the full interview available tomorrow on our YouTube channel from 15:00pm and on our website www.h**pandcbdmedia.com 💚
TODAY'S PREMIERE: Tune into our H**p & CBD Media Youtube to watch our first #fullspectrumroundtable talk with our industry leaders!
-
A full evening discussing all aspects of the H**p and cbd industry with lots of great points of view and lots to get YOUR thoughts on! Don’t forget to tune in this afternoon to be the first to see the episode!
Subscribe to our YouTube now to get an alert for the PREMIERE! https://lnkd.in/gyBR-qe
Featuring...
Mike Harlington - CTA
Robert Jappie - Mackrell Turner Garrett
Dr. Dani Gordon
Tim Phillips - CBD Intel
Callie Blackwell - The Cannabis Activist
Robert Sidebottom - H**p & CBD Expo
Prof. Graeme Close - Professional sports nutritionist
Tom Prendergast - H**p & CBD Expo
www.h**pandcbdmedia.com #h**p #cbd #cannabidiol #cannabis #media #discussions #industryleaders
